Home › Bronchial Cancer › Michigan
Bronchial Cancer clinical trials in Michigan
5 studies for Bronchial Cancer are looking for participants at sites in Michigan.
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- START Midwest, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Michigan, Ann Arbor
- The Cancer & Hematology Centers, Grand Rapids
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Henry Ford Cancer Institute, Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07185997Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Karmanos Cancer Institute, Detroit
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 26, 2026 · NCT04614103Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT02984761From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.